Patents Assigned to NUBIOME, INC.
  • Use of immobilization particles for removal of microorganisms and/or chemicals
    Patent number: 11083746
    Abstract: Method for immobilizing a target microorganism or target chemical found in a mammal includes introducing into a gastrointestinal tract of the mammal immobilization particles including immobilization molecules capable of attaching to the target microorganism or the target chemical, which immobilization molecules are attached to one or more portions of a structure that is capable of inhibiting contact between tissues of the gastrointestinal tract and the target microorganisms or target chemicals attached to the immobilization molecules.
    Type: Grant
    Filed: March 29, 2019
    Date of Patent: August 10, 2021
    Assignee: NuBiome, Inc.
    Inventor: Brian C. Lue
  • Treatment for gastroesophageal reflux disease caused by a neurological disorder
    Patent number: 10617727
    Abstract: An embodiment is a method of mitigating or treating Gastroesophageal Reflux Disease (GERD) caused by a neurological disorder that includes administering an effective amount of a medicament that includes a supernatant resulting from culturing Lactobacillus bulgaricus B-30892 bacteria to a human to mitigate or treat GERD caused by a neurological disorder.
    Type: Grant
    Filed: February 15, 2018
    Date of Patent: April 14, 2020
    Assignee: NuBiome, Inc.
    Inventor: Brian C. Lue
  • Treatment and prophylaxis for neurological conditions and diseases
    Patent number: 10363279
    Abstract: An embodiment is a method of preventing, mitigating or treating neurological conditions and diseases that includes administering an effective amount of a medicament comprised of Lactobacillus bulgaricus B-30892 and/or a supernatant resulting from culturing Lactobacillus bulgaricus B-30892 and/or bioactive materials resulting from culturing Lactobacillus bulgaricus B-30892 to a human to prevent, mitigate or treat neurological conditions and diseases.
    Type: Grant
    Filed: February 17, 2017
    Date of Patent: July 30, 2019
    Assignee: NuBiome, Inc.
    Inventor: Brian C. Lue
  • Use of immobilization particles for removal of microorganisms and/or chemicals
    Patent number: 10245279
    Abstract: Method for immobilizing a target microorganism or target chemical found in a mammal includes introducing into a gastrointestinal tract of the mammal immobilization particles including immobilization molecules capable of attaching to the target microorganism or the target chemical, which immobilization molecules are attached to one or more portions of a structure that is capable of inhibiting contact between tissues of the gastrointestinal tract and the target microorganisms or target chemicals attached to the immobilization molecules.
    Type: Grant
    Filed: January 20, 2016
    Date of Patent: April 2, 2019
    Assignee: NuBiome, Inc.
    Inventor: Brian C. Lue
  • Treatment and prophylaxis for lupus
    Patent number: 10245289
    Abstract: An embodiment is a method of preventing, mitigating or treating Lupus that includes administering an effective amount of a medicament to a human comprised of Lactobacillus bulgaricus B-30892 and/or a supernatant resulting from culturing Lactobacillus bulgaricus B-30892 and/or bioactive materials resulting from culturing Lactobacillus bulgaricus B-30892 to prevent, mitigate or treat Lupus.
    Type: Grant
    Filed: December 14, 2016
    Date of Patent: April 2, 2019
    Assignee: NuBiome, Inc.
    Inventor: Brian C. Lue
  • Compact, low cost shrink labeler
    Patent number: 10077128
    Abstract: One embodiment is a shrink labeler for use to shrink a shrink label onto a bottle including: a containment wall having a gas/steam inlet; and a showerhead container capable of holding the bottle in close proximity to orifices disposed therein and having an aperture through which the bottle may be introduced thereinto; wherein the gas/steam inlet is coupled to a plenum disposed between the containment wall and the showerhead container.
    Type: Grant
    Filed: February 10, 2017
    Date of Patent: September 18, 2018
    Assignee: NuBiome, Inc.
    Inventor: Brian C. Lue
  • Treatment and prophylaxis for gastroesophageal reflux disease
    Patent number: 9925225
    Abstract: An embodiment is a method of preventing, mitigating or treating Gastroesophageal Reflux Disease (GERD) that includes administering an effective amount of a medicament comprised of the Lactobacillus bulgaricus B-30892 strain and/or bioactive compounds from its supernatant to a human to prevent, mitigate or treat GERD.
    Type: Grant
    Filed: September 24, 2015
    Date of Patent: March 27, 2018
    Assignee: NuBiome, Inc.
    Inventor: Brian C. Lue
  • Treatment and prophylaxis for obsessive compulsive disorder
    Patent number: 8927242
    Abstract: An embodiment is a method of preventing, mitigating or treating Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS) that includes administering an effective amount of a medicament comprised of Streptococcus oralis 89a to a human to prevent, mitigate or treat PANDAS.
    Type: Grant
    Filed: May 3, 2013
    Date of Patent: January 6, 2015
    Assignee: NuBiome, Inc.
    Inventors: Brian C. Lue, Fredrick C. Westall
  • Treatment and Prophylaxis for Obsessive Compulsive Disorder
    Publication number: 20130302296
    Abstract: An embodiment is a method of preventing, mitigating or treating Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS) that includes administering an effective amount of a medicament comprised of Streptococcus oralis 89a to a human to prevent, mitigate or treat PANDAS.
    Type: Application
    Filed: May 3, 2013
    Publication date: November 14, 2013
    Applicant: NuBiome, Inc.
    Inventors: Brian C. Lue, Fredrick C. Westall
  • Immobilization Particles for Removal of Microorganisms and/or Chemicals
    Publication number: 20120108787
    Abstract: An immobilization particle for immobilizing a target microorganism or target chemical found in or on a mammal that includes: immobilization molecules capable of attaching to a target microorganism or a target chemical, which immobilization molecules are attached to one or more portions of a substrate structure; wherein the substrate structure is capable of inhibiting contact between tissues of the mammal and target microorganisms or target chemicals attached to immobilization molecules attached to the one or more portions.
    Type: Application
    Filed: January 5, 2012
    Publication date: May 3, 2012
    Applicant: NUBIOME, INC.
    Inventor: Brian C. Lue
  • Treatment/Cure of Autoimmune Disease
    Publication number: 20110081320
    Abstract: An embodiment entails administering an effective amount of a product such as a protease or a source of a protease that destroys or deactivates an immunogen, mimic or antigen specific to a particular autoimmune disease before it encounters the immune system of a patient.
    Type: Application
    Filed: October 5, 2010
    Publication date: April 7, 2011
    Applicant: NUBIOME, INC.
    Inventors: Fredrick C. Westall, Richard Blankenbecler, Brian C. Lue